Vyteris, Inc. engages in the development and production of electronically controlled transdermal drug delivery systems that deliver drugs through the skin without using needles. The company was founded in 2000 as a spin out of the Transdermal Systems unit of Becton Dickinson. It was formerly known as Vyteris Holdings (Nevada), Inc. and changed its name to Vyteris, Inc. in May 2007. The company is headquartered in Fair Lawn, New Jersey. In 2011, Vyteros merged with MediSync BioServices, Inc., a CRO. Vyteris will now focus all its efforts on consolidating specialty businesses in the CRO, site management organization (SMO) and related services industry. As a result, the Company is currently discontinuing its drug delivery business and plans to monetize its proprietary active transdermal drug-delivery assets as soon as possible.

Acquired Companies: MediSync BioServices Inc.